Sheng F. Cai, MD, PhD, discusses the results of the BEAT AML master trial in patients with acute myeloid leukemia.
Sheng F. Cai, MD, PhD
Sheng F. Cai, MD, PhD, is a leukemia specialist and early drug development specialist at Memorial Sloan Kettering Cancer Center.
Articles by Sheng F. Cai, MD, PhD